celecoxib has been researched along with rabeprazole in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Esaki, M; Ishikawa, H; Kitazono, T; Kobayashi, H; Maehata, Y; Matsumoto, T; Miyazaki, M; Washio, E | 1 |
| Esaki, M; Hirano, A; Kitazono, T; Kobayashi, H; Maehata, Y; Matsumoto, T; Miyazaki, M; Nuki, Y; Umeno, J; Washio, E | 1 |
| Esaki, M; Nuki, Y | 1 |
| Srinivas, NR | 1 |
1 review(s) available for celecoxib and rabeprazole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for celecoxib and rabeprazole
| Article | Year |
|---|---|
Proton Pump Inhibitors Increase Incidence of Nonsteroidal Anti-Inflammatory Drug-Induced Small Bowel Injury: A Randomized, Placebo-Controlled Trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Capsule Endoscopy; Celecoxib; Double-Blind Method; Female; Healthy Volunteers; Humans; Incidence; Intestinal Diseases; Intestinal Mucosa; Japan; Male; Placebos; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Tertiary Care Centers | 2016 |
The influence of CYP2C19 polymorphisms on exacerbating effect of rabeprazole in celecoxib-induced small bowel injury.
Topics: Adult; Capsule Endoscopy; Celecoxib; Cytochrome P-450 CYP2C19; Double-Blind Method; Female; Genotype; Humans; Intestinal Diseases; Male; Middle Aged; Polymorphism, Genetic; Proton Pump Inhibitors; Rabeprazole; Young Adult | 2017 |
2 other study(ies) available for celecoxib and rabeprazole
| Article | Year |
|---|---|
Letter: CYP2C19 polymorphisms and exacerbation of rabeprazole's effects on celecoxib-induced small bowel injury-authors' reply.
Topics: Celecoxib; Cytochrome P-450 CYP2C19; Humans; Intestinal Diseases; Intestine, Small; Rabeprazole | 2017 |
Letter: CYP2C19 polymorphisms and exacerbation of rabeprazole's effects on celecoxib-induced small bowel injury.
Topics: Aryl Hydrocarbon Hydroxylases; Celecoxib; Cytochrome P-450 CYP2C19; Humans; Intestinal Diseases; Intestine, Small; Polymorphism, Genetic; Rabeprazole | 2017 |